Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · IEX Real-Time Price · USD
47.82
+0.49 (1.04%)
At close: Jul 19, 2024, 4:00 PM
49.56
+1.74 (3.64%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
Ionis Pharmaceuticals Revenue
Ionis Pharmaceuticals had revenue of $776.62M in the twelve months ending March 31, 2024, with 34.84% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $119.50M. In the year 2023, Ionis Pharmaceuticals had annual revenue of $787.65M with 34.10% growth.
Revenue (ttm)
$776.62M
Revenue Growth
+34.84%
P/S Ratio
8.99
Revenue / Employee
$837,778
Employees
927
Market Cap
6.98B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 787.65M | 200.28M | 34.10% |
Dec 31, 2022 | 587.37M | -223.09M | -27.53% |
Dec 31, 2021 | 810.46M | 81.19M | 11.13% |
Dec 31, 2020 | 729.26M | -393.34M | -35.04% |
Dec 31, 2019 | 1.12B | 522.93M | 87.20% |
Dec 31, 2018 | 599.67M | 85.50M | 16.63% |
Dec 31, 2017 | 514.18M | 141.40M | 37.93% |
Dec 31, 2016 | 372.78M | 89.07M | 31.40% |
Dec 31, 2015 | 283.70M | 69.54M | 32.47% |
Dec 31, 2014 | 214.16M | 66.88M | 45.41% |
Dec 31, 2013 | 147.29M | 45.24M | 44.33% |
Dec 31, 2012 | 102.05M | 2.96M | 2.99% |
Dec 31, 2011 | 99.09M | -9.39M | -8.65% |
Dec 31, 2010 | 108.47M | -13.13M | -10.80% |
Dec 31, 2009 | 121.60M | 14.41M | 13.44% |
Dec 31, 2008 | 107.19M | 48.85M | 83.72% |
Dec 31, 2007 | 58.34M | 43.49M | 292.65% |
Dec 31, 2006 | 14.86M | -25.27M | -62.98% |
Dec 31, 2005 | 40.13M | -2.49M | -5.84% |
Dec 31, 2004 | 42.62M | -7.37M | -14.73% |
Dec 31, 2003 | 49.99M | -30.19M | -37.65% |
Dec 31, 2002 | 80.18M | 26.91M | 50.51% |
Dec 31, 2001 | 53.27M | 16.02M | 43.00% |
Dec 31, 2000 | 37.26M | 3.33M | 9.82% |
Dec 31, 1999 | 33.93M | -5.25M | -13.39% |
Dec 31, 1998 | 39.17M | 6.45M | 19.71% |
Dec 31, 1997 | 32.72M | 10.06M | 44.39% |
Dec 31, 1996 | 22.66M | 6.70M | 41.94% |
Dec 31, 1995 | 15.97M | 454.00K | 2.93% |
Dec 31, 1994 | 15.51M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
The Ensign Group | 3.85B |
Jazz Pharmaceuticals | 3.84B |
Exelixis | 1.85B |
Penumbra | 1.10B |
Halozyme Therapeutics | 862.99M |
Repligen | 607.45M |
Tempus AI | 562.02M |
Ascendis Pharma | 357.63M |
IONS News
- 59 minutes ago - Ionis announces positive detailed results from the HALOS Study of ION582 in people with Angelman syndrome - PRNewsWire
- 2 days ago - Ionis to hold second quarter 2024 financial results webcast - PRNewsWire
- 4 days ago - Ionis completes enrollment in pivotal trial evaluating zilganersen in people living with Alexander disease - PRNewsWire
- 14 days ago - Ionis announces webcast to report HALOS study results for ION582 in Angelman syndrome - PRNewsWire
- 27 days ago - Ionis announces olezarsen FCS New Drug Application accepted for Priority Review and enrollment in Phase 3 sHTG program completed - PRNewsWire
- 4 weeks ago - M&A Is Back. 4 Stocks That Could Be Targets. - Barrons
- 4 weeks ago - Ionis announces expanded licensing agreement with Otsuka in Asia Pacific for investigational medicine donidalorsen in hereditary angioedema - PRNewsWire
- 4 weeks ago - Ionis to present at TD Cowen Genetic Medicines & RNA Summit - PRNewsWire